RESUMO
One hundred and sixty patients with hypertension complicating pregnancy [80 mild and severe treated with standard method, 80 mild and severe treated with standard method and solcoseryl intravenous infusion]. A significant improvement in both fetal birth and placental weight was found in patients receiving solcoseryl. There was a significant improvement in fetal apgar score at one minute when mothers given solcoseryl. Placental perivillous fibrin deposition and intervillous thrombosis was less in severe hypertensive cases receiving solcoseryl
Assuntos
Humanos , Feminino , Desenvolvimento Fetal/fisiologia , Desenvolvimento Fetal/efeitos dos fármacosRESUMO
This study includes 160 patients suffering from mild or severe pregnancy induced hypertension. Half of patients have received the ordinary lines of treatment of P.I.H., while the other half received this treatment in additional to Solcoseryl injection. It has been found that the patients who have received Solcoseryl therapy had a significant increase in the foetal movements, increased foetal biparietal diameter, and gave births to babies who had a higher birth weight and a higher apgar score [1 min and 5 min] than those who did not receive it
Assuntos
Feto , Bem-Estar Materno , Actiemil , Resultado da Gravidez , HipertensãoRESUMO
Low dose combined pills were investigated regarding its effect on the amount and total protein content of breast milk during the first six months post partum. No significant changes were found in these two parameters, except at the 4th months where the amount of breast milk in the medicated group was significantly lower than the control group
Assuntos
Feminino , Lactação/efeitos dos fármacos , Aleitamento MaternoRESUMO
The pre-nursing serum prolactin levels were determine in two groups of lactating and menstruating mothers, six months after delivery, and fitted with Cu T-200 IUD and Progestasert intrauterine system immediately postpartum. No significant differences in the premenstrual and menstrual mean +/- SE prolactin values were noted in comparison with matched group not using any form of contraception. A uniform rise in prolactin levels was observed with the onset of menses in the three categories studied, but this was only significant in the Prgestasert group. Serum prolactin levels in lactating and amenorrheic mothers, two months after delivery did not reveal significant changes when Cu T-200 and Progestasert IUD users were compared